121 related articles for article (PubMed ID: 28255965)
1. High-intensity Exercise in Men with Type 1 Diabetes and Mode of Insulin Therapy.
Gawrecki A; Naskret D; Niedzwiecki P; Duda-Sobczak A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Int J Sports Med; 2017 Apr; 38(4):329-335. PubMed ID: 28255965
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study.
Moniotte S; Owen M; Barrea T; Robert A; Lysy PA
Pediatr Diabetes; 2017 Dec; 18(8):925-933. PubMed ID: 28251726
[TBL] [Abstract][Full Text] [Related]
4. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
5. Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients.
Yardley JE; Iscoe KE; Sigal RJ; Kenny GP; Perkins BA; Riddell MC
Diabetes Technol Ther; 2013 Jan; 15(1):84-8. PubMed ID: 23216304
[TBL] [Abstract][Full Text] [Related]
6. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
7. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
8. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
9. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy.
Gomez AM; Gomez C; Aschner P; Veloza A; Muñoz O; Rubio C; Vallejo S
J Diabetes Sci Technol; 2015 May; 9(3):619-24. PubMed ID: 25555390
[TBL] [Abstract][Full Text] [Related]
10. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
11. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
[TBL] [Abstract][Full Text] [Related]
12. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
[TBL] [Abstract][Full Text] [Related]
13. Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall.
Riddell MC; Zaharieva DP; Tansey M; Tsalikian E; Admon G; Li Z; Kollman C; Beck RW
Pediatr Diabetes; 2019 Feb; 20(1):99-106. PubMed ID: 30467929
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
15. No Disadvantage to Insulin Pump Off vs Pump On During Intermittent High-Intensity Exercise in Adults With Type 1 Diabetes.
Zaharieva DP; Cinar A; Yavelberg L; Jamnik V; Riddell MC
Can J Diabetes; 2020 Mar; 44(2):162-168. PubMed ID: 31416695
[TBL] [Abstract][Full Text] [Related]
16. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
17. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Pettus J; Edelman SV
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
[TBL] [Abstract][Full Text] [Related]
18. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
[TBL] [Abstract][Full Text] [Related]
19. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P
Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393
[TBL] [Abstract][Full Text] [Related]
20. Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial.
Heise T; Bain SC; Bracken RM; Zijlstra E; Nosek L; Stender-Petersen K; Rabøl R; Rowe E; Haahr HL
Diabetes Obes Metab; 2016 Feb; 18(2):196-9. PubMed ID: 26450456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
